Latest stories on REPL
REPL Stock Clocks Worst Day In Over 3 Months — New FDA Documents Leave Wall Street Awaiting Another Rejection For Cancer Drug
Stocktwits News28 · bearishgeneral
Replimune Is Locked in a Standoff With Regulators. Here Is What It Means for the Stock.
Barron's38 · neutralgeneral
FDA Staff Raise Concerns On Replimune’s Skin Cancer Drug – REPL Stock Crashes 32% Today Ahead Of Advisory Meeting This Week
Stocktwits News28 · bearishproduct/pr
Replimune Shares Fall on Negative FDA Comments Ahead of AdCom Meeting
Morningstar28 · bearishgeneral
US FDA staff cast doubt on Replimune cancer drug's benefit; shares slide
Reuters28 · bearishgeneral
Why is Replimune stock plunging today?
Investing.com Markets34 · bearishgeneral
Replimune stock tumbles 20% after FDA raises efficacy concerns
Investing.com Markets32 · bearishearnings
Why is Replimune stock sliding today?
Investing.com Markets42 · neutralgeneral
FDA Showdown Week: CAPR, NRXP, REPL And MRNA Face Make-Or-Break Regulatory Decisions
Stocktwits News50 · neutralgeneral
Replimune's RP1 Drug Probably Works, But It's Not A Buy Yet
Seeking Alpha38 · neutralanalyst
Four stock-moving events to watch as FDA revives AdComs
Seeking Alpha56 · neutralgeneral
Replimune: Stock Buoyant On Third Try At RP1 Approval - FDA AdCom May Be Crucial
Seeking Alpha58 · neutralproduct/pr
Replimune Group, Inc. (REPL) files 8-K
SEC 8-K50 · neutralgeneral
Replimune Group GAAP EPS of -$3.38 misses by $0.02
Seeking Alpha34 · bearishearnings
Replimune Reports Fiscal Fourth Quarter and Year End 2026 Financial Results and Provides Corporate Update | REPL Stock News
StockTitan63 · neutralproduct/pr
FDA Sets August 2 Target Date for Replimune’s RP1 Melanoma Therapy—Advisory Meeting Slated for Late July
MarketChameleon73 · bullishproduct/pr
Replimune’s RP1 BLA Resubmission Accepted for Review
TipRanks63 · neutralgeneral
Replimune to face AdCom panel as lead drug accepted for FDA review
Seeking Alpha56 · neutralgeneral
Replimune Group, Inc. (REPL) files 8-K
SEC 8-K50 · neutralgeneral
Replimune Announces FDA Acceptance of RP1 Biologics License Application Resubmission for Advanced Melanoma | REPL Stock News
StockTitan63 · neutralproduct/pr
Regenxbio, Replimune among gainers after FDA U-turn on UniQure
Seeking Alpha67 · bullishgeneral
Replimune: Modeling The Coin Flip Of FDA Approval
Seeking Alpha53 · neutralgeneral
Replimune got another attempt at lead drug after White House intervention: WSJ
Seeking Alpha58 · neutralgeneral